High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro
Abstract Clostridioides difficile is an enteric pathogen responsible for causing debilitating diarrhea, mostly in hospitalized patients. The bacterium exploits on microbial dysbiosis induced by the use of antibiotics to establish infection that ranges from mild watery diarrhea to pseudomembranous co...
Guardado en:
Autores principales: | Rusha Pal, Mingji Dai, Mohamed N. Seleem |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a361d52222ab4e87a199b8e5c805e5c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
por: Nader S. Abutaleb, et al.
Publicado: (2021) -
Epidemiology of Clostridioides difficile in South Africa.
por: Pieter de Jager, et al.
Publicado: (2021) -
Faecal transplantation and Clostridioides difficile infection
por: Knežević Darija A., et al.
Publicado: (2021) -
Effective inhibition of Clostridioides difficile by the novel peptide CM-A.
por: Sirirak Arthithanyaroj, et al.
Publicado: (2021) -
Plasmid-mediated metronidazole resistance in Clostridioides difficile
por: Ilse M. Boekhoud, et al.
Publicado: (2020)